All News
Filter News
Found 808,445 articles
-
AARP Alarmed by SEC's Approval of Final 'Regulation Best Interest'
6/5/2019
The following is a statement by AARP Executive Vice President and Chief Advocacy and Engagement Officer Nancy LeaMond on the Securities and Exchange Commission's approval today of "Regulation Best Interest" and its final three-part rule on the standards of conduct applicable to financial professionals and related disclosure form:
-
CeQur Appoints Bradley Paddock Chief Executive Officer
6/5/2019
CeQur® announced that the company has appointed Bradley Paddock as chief executive officer, effective today.
-
Jeff Settleman, Ph.D., Joins Pfizer to Lead Oncology Research & Development
6/5/2019
Pfizer Inc. (NYSE: PFE) announced today that Jeff Settleman, Ph.D., will join the company as Senior Vice President and Group Head of Oncology Research & Development, leading all early oncology research, from discovery to proof of concept clinical studies
-
Lonza to Host New Webinar Titled "Know Your Enemy: Mycoplasma Contamination in Cell Culture"
6/5/2019
On 18 June 2019, Lonza will host a free 60-minute webinar on mycoplasma contamination and how Lonza’s MycoAlert™ Assay enables simple and fast detection of mycoplasma contaminants in cell cultures.
-
d.health Summit Addresses Social Determinants of Health
6/5/2019
Each day 10,000 Americans reach the age of 65. Providing medical care alone is not enough.
-
DelMar Pharmaceuticals Announces Closing of Financing
6/5/2019
DelMar Pharmaceuticals, Inc. (Nasdaq: DMPI) ("DelMar" or the "Company"), a biopharmaceutical company focused on the development and commercialization of new cancer therapies, today announced the closing of its previously announced registered direct offering of 1,170,000 shares of common stock and, in a concurrent private placement
-
Polarean Imaging Plc: New System Order
6/5/2019
Polarean Imaging plc (AIM: POLX), the medical-imaging technology company, with a proprietary drug-device combination product for the magnetic resonance imaging (MRI) market, announces the Company has received its latest research unit order for a 9820 Xenon Polariser system from The Hospital for Sick Children (“SickKids”) in Toronto www.sickkids.ca.
-
Stepping Up Clinical Laboratory QC: Advanced Instruments Launches Osmometer Peer Group Program to Allow Labs to Compare Data
6/5/2019
Advanced Instruments, LLC announces the launch of their new web-based Advanced QC™ Peer Group program that allows laboratories to compare their osmometer serum and urine QC to their peers' data on a real-time and monthly basis.
-
NeurologyLive™ Expands Strategic Alliance Partnership Program with Cleveland Clinic
6/5/2019
NeurologyLive™, a multimedia platform dedicated to providing health care professionals treating neurological diseases with direct access to expert-driven, practice-changing news and insights in neurology, announces the addition of Cleveland Clinic to its Strategic Alliance Partnership (SAP) program.
-
Trauma and Small Bone & Joint Reconstruction Markets to Grow by More Than $600 Million Each by 2022 – New Study by iData Research
6/5/2019
iData Research, a global consulting and market research firm, just announced the publication of new research in the orthopedic device market
-
Mallinckrodt Announces Agreement In Principle With U.S. Department Of Justice On Legacy Questcor Sales And Marketing Activities; Responds To Government Civil Litigation Involving Legacy Questcor Charitable Foundation Activities
6/5/2019
Mallinckrodt plc (NYSE: MNK), a global specialty biopharmaceutical company, today reported the company has reached an agreement in principle with the U.S. Department of Justice (DOJ) to resolve the previously disclosed government investigation of Questcor's legacy sales and marketing activities, which is still subject to the finalization of certain terms.
-
Pelican BioThermal Opens Mexico City Network Station & Service Center
6/5/2019
Pelican BioThermal, the global name in temperature-controlled packaging, announces the opening of a new network station and service center in Mexico City, Mexico. Mexico is the second largest pharmaceutical market in Latin America — and 12th in the world — with more than $1.75 billion in pharmaceutical exports since 2015.
-
U.S. Anesthesia, Respiratory and Sleep Management Device Market to Reach over $5.8 billion by 2025 – New Study by iData Research
6/5/2019
According to the latest suite of reports by iData Research, the United States anesthesia, respiratory and sleep management device market was valued at $4.4 billion in 2018, and is expected to exceed $5.8 billion by 2025.
-
MiMedx Issues New Presentation for Investors in Advance of 2018 Annual Meeting
6/5/2019
MiMedx Group, Inc. (OTC PINK: MDXG) ("MiMedx" or the "Company"), an industry leader in advanced wound care and an emerging therapeutic biologics company, today released an investor presentation summarizing the reasons why the Company believes shareholders should support the Company's three nominees for the Board of Directors (the "Board") at the 2018 annual meeting of shareholders
-
Takeda Provides Update on TOURMALINE-AL1 Phase 3 Trial in AL Amyloidosis
6/5/2019
Takeda Pharmaceutical Company Limited (TSE: 4502/NYSE: TAK) today announced that the Phase 3 TOURMALINE-AL1 clinical trial in patients with relapsed or refractory systemic light-chain (AL) amyloidosis did not meet the first of two primary endpoints.
-
Banner Health addressing drug shortages through Premier's ProvideGx™ generics sourcing subsidiary
6/5/2019
Banner Health will partner with ProvideGx™, a new generic medication supply company, to help ensure that physicians and patients have access to drugs that would otherwise be in short supply.
-
BRAINBox Solutions™ Receives Breakthrough Device Designation from FDA for First-of-Kind Device to Aid in Concussion Diagnosis and Prognosis
6/5/2019
BRAINBox Solutions today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation for the company's BRAINBox TBI (Traumatic Brain Injury) test in development, the first to aid in both the diagnosis and prognosis of mild TBI (concussion).
-
ASCO 2019: Immunotherapy better than aggressive chemotherapy as first treatment option for recurrent head and neck cancer
6/5/2019
Immunotherapy used with chemotherapy or on its own is a better first-line treatment for people with head and neck cancer that has returned than standard aggressive chemotherapy, new clinical trial results show.
-
Congress Passes Emergency Nurses Association-Supported PAHPA Act
6/5/2019
The Emergency Nurses Association on Wednesday praised the House of Representative's passage this week of the Pandemic and All Hazards Preparedness and Advancing Innovation Act which includes ENA priority legislation that will lead to the development of a collaborative civilian and military trauma exchange program.
-
Vaccitech Universal flu vaccine passes Phase 2b clinical development milestones
6/5/2019
Vaccitech Ltd. announces that it has administered its pandemic universal influenza A vaccine MVA-NP+M1 (VTP-100) to the first participants in a Flu 010 study – a Phase 2b, randomised, double-blind, placebo controlled, influenza challenge study being conducted in Antwerp, Belgium.